To identify factors associated with referral to an exclusive palliative care unit (PCU) in patients with colorectal cancer (CRC).
Methods:
Retrospective cohort study with patients having CRC of both sexes treated at a hospital unit, aged ≥20 years. Data were extracted from the medical records of pretreatment patients between January 2008 and August 2014. The outcome was referral to the PCU within 5 years. Logistic regression analyses were performed to assess whether sociodemographic, clinical, nutritional, and biochemistry data were associated to referral, generating odds ratios (OR), and 95% confidence intervals (CI).
Results:
Four hundred fifteen patients were evaluated. The Patient-Generated Subjective Global Assessment demonstrated a prevalence of malnutrition of 57.3%. One hundred one (24.3%) patients were referred to the PCU after 16.3 months (interquartile range: 7.2-33.5). These patients were more likely to be at an advanced stage of the disease and have malnutrition and exacerbated systemic inflammation. Tumor stage III and IV (OR: 2.05; 95% CI: 1.12-3.76) and neutrophil-to-lymphocyte ratio (NLR) ≥3 (OR: 1.89; 95% CI: 1.12-3.17) were predictors of an increased chance of referral to the PCU.
Conclusion:
Advanced disease stage and NLR were associated with referral of patients with CCR to a PCU.
SiegelRLMillerKDJemalA. Cancer Statistics, 2017. CA Cancer J Clin. 2017;67(1):7–30.
2.
SiegelRLMillerKDFedewaSA, et al.Colorectal cancer statistics, 2017. CA Cancer J Clin. 2017;67(3):177–193.
3.
BailiPDi SalvoFMarcos-GrageraR, et al.Age and case mix-standardised survival for all cancer patients in Europe 1999-2007: results of EUROCARE-5, a population-based study. Eur J Cancer. 2015;51(15):2120–2129.
4.
OudhoffJPTimmermansDRKnolDLBijnenABvan der WalG. Waiting for elective general surgery: impact on health related quality of life and psychosocial consequences. BMC Public Health. 2007;19(7):164.
5.
van den BerghRCEssink-BotMLRoobolMJ, et al.Anxiety and distress during active surveillance for early prostate cancer. Cancer. 2009;115(17):3868–3878.
6.
BoltEEPasmanHRWillemsDOnwuteaka-PhilipsenBD. Appropriate and inappropriate care in the last phase of life: an explorative study among patients and relatives. BMC Health Serv Res. 2016;16(1):655.
7.
World Health Organization (WHO). National Cancer Control Program. 2nd ed. Geneve, Switzerland: Policies and managerial guidelines; 2002.
8.
SchenkerYCrowley-MatokaMDohanD, et al.Oncologist factors that influence referrals to subspecialty palliative care clinics. J Oncol Pract. 2014;10(2):e37–e44.
9.
HuiDMengYCBrueraS, et al.Referral criteria for outpatient palliative cancer care: a systematic review. Oncologist. 2016;21(7):895–901.
10.
HuiDMoriMWatanabeSM, et al.Referral criteria for outpatient specialty palliative cancer care: an international consensus. Lancet Oncol. 2016;17(12):e552–e559.
11.
HuiD. Prognostication of survival in patients with advanced cancer: predicting the unpredictable?Cancer Control. 2015;22(4):489–497.
12.
HeflerLAConcinNHofstetterGJ, et al.Serum C-reactive protein as independent prognostic variable in patients with ovarian cancer. Clin Cancer Res. 2008;14(3):710–714.
13.
TsaiPLSuWJLeungWHLaiCTLiuCK. Neutrophil-lymphocyte ratio and CEA level as prognostic and predictive factors in colorectal cancer: a systematic review and meta-analysis. J Cancer Res Ther. 2016;12(2):582–589.
14.
YangHBXingMMaLNFengLXYuZ. Prognostic significance of neutrophil-lymphocyte ratio/platelet-lymphocyte ratio in lung cancers: a meta-analysis. Oncotarget. 2016;47(7):76769–76778.
15.
VergidisJGreshamGLimHJ, et al.Impact of weight changes after the diagnosis of stage III colon cancer on survival outcomes. Clin Colorectal Canc. 2016;15(1):16–23.
16.
LiesenfeldDBGrapovDFahrmannJF, et al.Metabolomics and transcriptomics identify pathway differences between visceral and subcutaneous adipose tissue in colorectal cancer patients: the Colo care study. Am J Clin Nutr. 2015;102(2):433–443.
17.
MeyerhardtJAKroenkeCHPradoCM, et al.Association of weight change after colorectal cancer diagnosis and outcomes in the Kaiser Permanente northern California population. Cancer Epidemiol Biomarkers Prev. 2017;26(1):30–37.
18.
Jager-WittenaarHOtteryFD. Assessing nutritional status in cancer: role of the patient-generated subjective global assessment. Curr Opin Clin Nutr Metab Care. 2017;20(5):322–329.
19.
MartinLSenessePGioulbasanisI, et al.Diagnostic criteria for the classification of cancer-associated weight loss. J Clin Oncol. 2015;33(1):90–99.
20.
HaramABolandMRKellyMEBolgerJCWaldronRMKerinMJ. The prognostic value of neutrophil-to-lymphocyte ratio in colorectal cancer: a systematic review. J Surg Oncol. 2017;115(4):470–479.
21.
HuangXZChenWJZhangX, et al.An elevated platelet-to-lymphocyte ratio predicts poor prognosis and clinic pathological characteristics in patients with colorectal cancer: a meta-analysis. Dis Markers. 2017;2017:1053125.
22.
MedeirosGCBergmannAAguiarSS. Análise dos determinantes que influenciam o tempo para o início do tratamento de mulheres com câncer de mama no Brasil. Cad Saude Publica. 2015;31(6):1269–1282.
23.
ThulerLCSBergmannACasadoL. Perfil das pacientes com câncer do colo do útero no Brasil, 2000-2009: estudo de base secundária. Rev Bras Cancerol. 2012;58(3):351–357.
24.
SealyMJNijholtWStuiverMM, et al.Content validity across methods of malnutrition assessment in patients with cancer is limited. J Clin Epidemiol. 2016;76:125–136.
25.
CoronhaALCamiloMERavascoP. A importância da composição corporal no doente oncológico. qual a evidência?Acta Med Port. 2011;24(4):769–778.
26.
CarvalhoRTParsonsHA(Organizers). Agencia Nacional De Cuidados Paliativos (ANCP). Manual de Cuidados Paliativos ANCP, 2nd ed. Porto Alegre: Sulina; 2012.
27.
HuiDKimSHKwonJH, et al.Access to palliative care among patients treated at a comprehensive cancer center. Oncologist. 2012;17(12):1574–1580.
28.
JanahAGauthierLRMorinL, et al.Access to palliative care for cancer patients between diagnosis and death: a national cohort study. Clin Epidemiol. 2019;11:443–455.
29.
TenoJMGozaloPLBynumJPW L, et al.Change in end-of-life care for Medicare beneficiaries: site of death, place of care, and health care transitions in 2000, 2005, and 2009. JAMA2013;309(5):470–477.
30.
TemelJSGreerJAMuzikanskyA, et al.Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010;363(8):733–742.
31.
ReadJAChoySTBealePJClarkeSJ. Evaluation of nutritional and inflammatory status of advanced colorectal cancer patients and its correlation with survival. Nutr Cancer. 2006;55(1):78–85.
32.
DouglasEMcMillanCD. Towards a simple objective framework for the investigation and treatment of cancer cachexia: the Glasgow prognostic score. Cancer Treat Rev. 2014;40(6):685–691.
33.
SilvaJRWiegertEVMOliveiraLCCalixto-LimaL. Different methods for diagnostic of sarcopenia and its association with nutritional status and survival in patients with advanced cancer in palliative care. Nutrition. 2019;60:48–52.
34.
CunhaMSWiegertEVMCalixto-LimaLOliveiraLC. Relationship of nutritional status and inflammation with survival in patients with advanced cancer in palliative care. Nutrition2108;51-52:98–103.
35.
CaroMMMCandelaCGRabanedaRC, et al.Evaluación del riesgo nutricional e instauración de soporte nutricional en pacientes oncológicos, segúnel protocolo del grupo español de Nutrición y Cáncer. Nutr Hosp. 2008;23(5):458–468.
36.
HuiDKimSHRoquemoreJDevRChisholmGBrueraE. Impact of timing and setting of palliative care referral on quality of end-of-life care in cancer patients. Cancer. 2014;120(11):1743–1749.
37.
BrueraEYennurajalingamS. Palliative care in advanced cancer patients: how and when?Oncologist. 2012;17(2):267–273.
38.
AzabBShahNRadbelJ, et al.Pretreatment neutrophil/lymphocyte ratio is superior to platelet/lymphocyte ratio as a predictor of long-term mortality in breast cancer patients. Med Oncol. 2013;30(1):432.
39.
VayrynenJPTuomistoAKlintrupKMäkeläJKarttunenTJMäkinenMJ. Detailed analysis of inflammatory cell infiltration in colorectal cancer. Br J Cancer2013;109(7):1839–1847.
40.
NakamuraYWatanabeRKatagiriM, et al.Neutrophil/lymphocyte ratio has a prognostic value for patients with terminal cancer. World J. Surg Oncol. 2016;14:148.
